Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Tests tucatinib and osimertinib in brain tumors and cancer spread to the brain
Tests tucatinib and osimertinib in adults with brain tumors or cancer spread to the brain.
Key facts
- Who runs it
- Amsterdam UMC Stichting
- Where
- Amsterdam, NetherlandsSee the site
- Trial code
- Registry title
- Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 20 people, planned
- Started
- 26 May 2026
- Expected to end
- 1 Oct 2027
- Type of study
- Interventional
- Record updated
- 25 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with breast cancer, non-small cell lung cancer or glioblastoma (a brain tumour). It studies how the drugs tucatinib and osimertinib behave in brain tumours.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- The record names breast cancer, non-small cell lung carcinoma and glioblastoma; no stage is given.
Main reasons for not taking part
- Healthy volunteers cannot join.
Where in Netherlands
- Amsterdam UMC StichtingAmsterdam, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests tucatinib and osimertinib in brain tumors and cancer spread to the brainGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 25 February 2026